Australian Genomics is now inviting expressions of interest for new Rare Disease Flagship projects, to commence in 2018 and run for two years.
Australian Genomics has implemented a program of research to demonstrate how the application of genomic data impacts the care of patients across a range of disorders. Our clinical flagships are central to this research model: they are nationally coordinated projects, founded in clinical practice, driving data through our programs to enable real-time evaluation of the impact of genomics on patient care.
Applications for Rare Disease Flagships (2018 – 2020) are now open and will close 30 September 2017.
For more information or a copy of the application form, please contact Tiffany Boughtwood (Tiffany.Boughtwood@mcri.edu.au / 03 9936 6321).